PRETREATMENT OF P815 MASTOCYTOMA CELLS WITH INHIBITORS OF PROTEIN SYNTHESIS REDUCES THEIR SUSCEPTIBILITY TO LYSIS BY CYTOTOXIC THYMUS-DERIVED LYMPHOCYTESDUPUY D'ANGEAC A; HALE AH.1980; CELL. IMMUNOL.; ISSN 0008-8749; USA; DA. 1980; VOL. 55; NO 2; PP. 342-354; BIBL. 34 REF.Article

ANALYSIS OF THE SUBPOPULATIONS OF T BLASTS BEARING INSULIN RECEPTORS OBTAINED BY 1-G VELOCITY SEDIMENTATION OF MURINE MIXED LYMPHOCYTE CULTURESHELDERMAN JH; STROM TB; DUPUY D'ANGEAC A et al.1979; TRANSPLANT. PROC.; USA; DA. 1979; VOL. 11; NO 2; PP. 1385-1386; BIBL. 5 REF.Article

USE OF CONCANAVALIN A TO ANALYSE THE MECHANISM OF MEMORY CELL DIFFERENTIATION INTO KILLER CELLSREME TX; DUPUY D'ANGEAC A; RADAL M et al.1979; ANN. IMMUNOL.; FRA; DA. 1979; VOL. 130; NO 6; PP. 827-840; ABS. FRE; BIBL. 24 REF.Article

Mitogenic effect of PMA + IL 2 on subpopulations of corticoresistant thymocytesDUPUY D'ANGEAC, A; MONIS, M; REME, T et al.The Journal of immunology (1950). 1986, Vol 137, Num 11, pp 3501-3508, issn 0022-1767Article

5'-Nucleotidase activity of murine T-cell subpopulations separated according to their Lyt2 and L3T4 phenotypesDORNAND, J; MONIS, M; DUPUY D'ANGEAC, A et al.Cellular immunology (Print). 1986, Vol 103, Num 1, pp 133-139, issn 0008-8749Article

Differential requirements for the induction of interleukin 2 responsiveness in L3T4⁺ and Lyt-2⁺ T cell subsetsERARD, F; NAVHOLZ, M; DUPUY-D'ANGEAC, A et al.The Journal of experimental medicine. 1985, Vol 162, Num 5, pp 1738-1743, issn 0022-1007Article

Interleukin 2 (IL 2) inhibitor in rheumatoid synovial fluid : correlation with prognosis and soluble IL 2 receptor levelsMIOSSEC, P; ELHAMIANI, M; CHICHEHIAN, B et al.Journal of clinical immunology. 1990, Vol 10, Num 2, pp 115-120, issn 0271-9142, 6 p.Article

Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymona cell lineDORNAND, J; BOUABOULA, M; DUPUY D'ANGEAC, A et al.Journal of cellular physiology. 1992, Vol 151, Num 1, pp 71-80, issn 0021-9541Article

Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis : correlation with duration of diseaseDUPUY D'ANGEAC, A; MONIER, S; JORGENSEN, C et al.Arthritis and rheumatism. 1993, Vol 36, Num 5, pp 608-612, issn 0004-3591Article

T cell receptor γ variable gene locus polymorphism in patients with rheumatoid arthritisCHAOUNI, I; LEFRANC, M.-P; DUPUY D'ANGEAC, A et al.Arthritis and rheumatism. 1992, Vol 35, Num 7, pp 756-760, issn 0004-3591Article

Contrasting effect of transforming growth factor type beta 1 (TGF-β1) on proliferation and interleukin-2 receptor expression in activated and rapidly cycling immature (CD3^-CD4^-CD8^-) thymocytesDUPUY D'ANGEAC, A; REME, T; MONIER, S et al.Journal of cellular physiology. 1993, Vol 154, Num 1, pp 44-52, issn 0021-9541Article

Loss of the G₁-S control of cyclin A expression during tumoral progression of Chinese hamster lung fibroblastsBARLAT, I; FESQUET, D; BRECHOT, C et al.Cell growth and differentiation. 1993, Vol 4, Num 2, pp 105-113, issn 1044-9523Article

Transforming growth factor type beta 1 (TGF-β1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell lineDUPUY D'ANGEAC, A; DORNAUD, J; EMONDS-ALT, X et al.Journal of cellular physiology. 1991, Vol 147, Num 3, pp 460-469, issn 0021-9541Article

T cell receptor distribution in rheumatoid synovial folliclesTRAVAGLIO-ENCINOZA, A; CHAOUNI, I; DERSIMONIAN, H et al.Journal of rheumatology. 1995, Vol 22, Num 3, pp 394-399, issn 0315-162XArticle